Overview
Meng Zhao, MD, PhD, joined Providence Swedish in July 2020. She received her medical degree from the Tongji University School of Medicine in Shanghai, China. Dr. Zhao completed an Internal Medicine Residency at the University of Texas Southwestern Medical Center, and then went on to study Oncology and Hematology at The Ohio State University Comprehensive Cancer Center and Wexner Medical Center in Columbus, OH. She is board certified by the American Board of Medical Oncology, and the American Board of Hematology. She is also a member of the American Society of Clinical Oncology. She earned a PhD in Cell and Molecular Biology at the University of Texas at Austin in Austin, TX. Philosophy of Care: Dr. Zhao focuses on personalized care and shared decision-making. She engages in open dialogues with patients and their families to discuss diagnoses and treatment options. Dr. Zhao blends clinical excellence with compassion and empathy. Her mission is to enhance the outcomes and quality of life for cancer patients and their families throughout their journey. Dr. Zhao, a skilled clinical researcher, previously held the role of clinical research director and principal investigator for diverse clinical trials. Now, in Swedish Cancer Institute, she continues her cancer research journey, benefiting patients with a robust clinical trials program and cutting-edge treatments.
Dr. Zhao is rated as an Experienced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. Her top areas of expertise are Chronic Inflammatory Demyelinating Polyneuropathy, Pleuropulmonary Blastoma, Neonatal Onset Multisystem Inflammatory Disease, and Lung Cancer.
Her clinical research consists of co-authoring 9 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
21605 76th Avenue West, Suite 200, Edmonds, WA
21601 76th Avenue West, Edmonds, WA 98026
Additional Areas of Focus
Dr. Zhao has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
The Association Of University Physicians
Petros Grivas is an Oncologist in Seattle, Washington. Dr. Grivas is rated as an Elite provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Endoscopy. Dr. Grivas is currently accepting new patients.
The Association Of University Physicians
Nina Lamble is a Hematologist Oncology specialist and a Hematologist in Seattle, Washington. Dr. Lamble is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Muscle Invasive Bladder Cancer. Dr. Lamble is currently accepting new patients.
Naixi Chen is a Hematologist Oncology specialist and a Hematologist in Renton, Washington. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Non-Muscle Invasive Bladder Cancer. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Scurvy, and Muscle Invasive Bladder Cancer. Dr. Chen is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic Inflammatory Demyelinating Polyneuropathy
- Experienced
- Acute Eosinophilic PneumoniaDr. Zhao isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Zhao isExperienced. Learn about Acute Mountain Sickness.
- Adult Soft Tissue SarcomaDr. Zhao isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Zhao isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- Alveolar Soft Part SarcomaDr. Zhao isExperienced. Learn about Alveolar Soft Part Sarcoma.